Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real-world Study of Paclitaxel Injection (Albumin-bound) for Neoadjuvant Treatment of Breast Cancer

NCT03959397 is registered in ClinicalTrials.gov with Jilin University as lead sponsor.

NCT NCT03959397
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03959397 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real-world Study of Paclitaxel Injection (Albumin-bound) for Neoadjuvant Treatment of Breast Cancer
Lead sponsor
Jilin University
Phase
Phase 2
Overall status
Unknown status
Start date
June 1, 2019
Completion date
December 1, 2024
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer stage